Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Senate Finance Drug Pricing Bill May Gain Traction As Panel’s Lead Health Staffer Joins CMS

Feb 17 2021

• By Cathy Kelly

Drug costs_1A_546120055_1200.jpg — Senate Finance Bill May Be Starting Point For New Drug Pricing Legislation

Related Content

Medicare Could Save More than $80bn With Price Inflation Rebates – CBO Score of Senate Bill

Mar 17 2020

PhRMA Willing To Contribute To Drug ‘Affordability’ – But Mum On How Much

Oct 11 2019

Calls For National Tech Assessment Program Could Be Amplified By Costs Of Cell, Gene Therapy

Feb 11 2021

Medicaid Rebate Reform: A Sign Of Minimal Drug Pricing Threats Or A Warning Of More To Come?

Feb 11 2021

Additional Topics

United States Legislation Pricing Debate Leadership Policy BioPharmaceutical

More from Legislation

More from Pink Sheet

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window